PAX8 and thyroid gland carcinoma: In another study with a large tumour panel, PAX8-positive tumours were frequently detected in renal cell carcinomas (90%), thyroid cancers (90%), endometrial cancers (84%), cervical adenocarcinomas (83%), and ovarian cancers (79%) [33].